Sharmila Pimple - Concepedia

Author

Sharmila Pimple

Also Known As

S Pimple, S. Pimple, SA Pimple, Sarah N. Pimple, Sharmila A Pimple, Sharmila A. Pimple, Sharmila Anil Pimple, Sharmila Pimple

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

Tata Memorial Hospital All India Institute of Medical Sciences Centre international de recherche sur le cancer Homi Bhabha National Institute Rajiv Gandhi Centre for Biotechnology

About

Sharmila Pimple is an author at Tata Memorial Hospital specializing in public health, preventive medicine, and health promotion.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Public Health	7	7	354
2	Medicine	4	4	90
3	Health Sciences	1	1	207
4	Management	1	1	14
5	Community Health Sciences	1	1	13

Sharmila Pimple

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort study Rengaswamy Sankaranarayanan, Priya R. Prabhu, Michael Pawlita, The Lancet Oncology	2015	244
Vaccine efficacy against persistent human papillomavirus (HPV) 16/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre, prospective, cohort study Partha Basu, Sylla G. Malvi, Smita Joshi, The Lancet Oncology	2021	243
An overview of the tobacco problem in India Gauravi Mishra, Sharmila Pimple, Surendra Shastri Indian Journal of Medical and Paediatric Oncology Tobacco CessationHarm ReductionGlobal TobaccoTobacco ControlPreventive Medicine	2012	207
An overview of prevention and early detection of cervical cancers Gauravi Mishra, Sharmila Pimple, Surendra Shastri Indian Journal of Medical and Paediatric Oncology	2011	172
Can a single dose of human papillomavirus (HPV) vaccine prevent cervical cancer? Early findings from an Indian study Rengaswamy Sankaranarayanan, Smita Joshi, Richard Muwonge, Vaccine	2018	163
Evaluation of immune response to single dose of quadrivalent HPV vaccine at 10-year post-vaccination Smita Joshi, Devasena Anantharaman, Richard Muwonge, Vaccine	2022	81
Knowledge of symptoms and risk factors of breast cancer among women: a community based study in a low socio-economic area of Mumbai, India Ranjan Kumar Prusty, Shahina Begum, Anushree Patil, BMC Women s Health	2020	80
Banning tobacco sales and advertisements near educational institutions may reduce students' tobacco use risk: evidence from Mumbai, India Ritesh Mistry, Mangesh S. Pednekar, Sharmila Pimple, Tobacco Control	2013	74
Compliance to Gutka ban and other provisons of COTPA in Mumbai Sharmila Pimple, Shilpa Gunjal, GA Mishra, Indian Journal of Cancer Tobacco ControlSubstance AbuseTobacco ProductsHealth PolicyGutka Ban	2014	43
Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9–14 years versus an established quadrivalent HPV vaccine in women aged 15–26 years in India: a randomised, active-controlled, multicentre, phase 2/3 trial Hitt Sharma, Sameer Parekh, Pramod Pujari, The Lancet Oncology VaccinationVaccine SafetyVaccinologyQuadrivalent Hpv VaccinePreventive Medicine	2023	35

Page 1